Pax5与CD103双染提高毛细胞白血病石蜡切片免疫组化特异性和敏感性
该研究开发了Pax5(核)与CD103(膜)双重免疫组化染色方法,用于石蜡切片中确认CD103表达于B细胞。分析了6例HCL、7例边缘区淋巴瘤、12例淋巴浆细胞淋巴瘤、7例滤泡性淋巴瘤、5例慢性淋巴细胞白血病、5例套细胞淋巴瘤、1例多发性骨髓瘤(淋巴细胞变异型)及3例无B细胞肿瘤累及的骨髓,结果显示仅HCL肿瘤细胞同时表达CD103和Pax5。该方法有助于评估HCL低水平累及及治疗后微小残留病。
要点
- Pax5/CD103双染可确认CD103在B细胞上的表达,提高HCL诊断特异性。
- 仅HCL肿瘤细胞同时阳性,其他B细胞淋巴瘤及正常骨髓不双阳。
- 双染法适用于HCL低水平累及和治疗后微小残留病评估。
核心结论
- Pax5与CD103双重免疫组化染色可提高石蜡切片中毛细胞白血病诊断的特异性和敏感性。
研究设计与样本
- 开发Pax5(核标记)与CD103(膜标记)双重免疫组化染色方法,在石蜡切片上实现原位免疫表型分析。
- 分析6例HCL、7例边缘区淋巴瘤、12例淋巴浆细胞淋巴瘤、7例滤泡性淋巴瘤、5例慢性淋巴细胞白血病、5例套细胞淋巴瘤、1例多发性骨髓瘤(淋巴细胞变异型)及3例无B细胞肿瘤累及的骨髓。
主要发现
- 双重染色证实仅HCL肿瘤细胞同时表达CD103和Pax5。
- 其他B细胞淋巴瘤及无B细胞肿瘤累及的骨髓未显示CD103与Pax5双阳性。
临床怎么用
- 双染法有助于在石蜡切片中确认CD103表达于B细胞,提高HCL诊断特异性。
- 适用于HCL低水平累及的评估及治疗后微小残留病的检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - In hematopathology practice, abnormal expression of CD103 on B cells is detected by flow cytometry in hairy cell leukemia (HCL) and, in combination with other phenotypic and morphologic findings, provides diagnostic specificity and sensitivity. Immunostaining on paraffin sections makes it possible to perform immunophenotyping in situ. However, normal bone marrow contains CD103-positive cells, which are not B cells, making it difficult to be certain about low-level involvement by HCL. OBJECTIVE: - To develop dual immunostaining for confirmation that CD103 is expressed in B cells, which may be highly desirable in assessing low-level involvement by HCL. DESIGN: - We developed a dual immunostaining approach using a B-cell marker, Pax5, expressed in the nucleus, in combination with a membrane marker, CD103. RESULTS: - We analyzed 6 HCLs, 7 marginal zone lymphomas, 12 lymphoplasmacytic lymphomas, 7 follicular lymphomas, 5 chronic lymphocytic leukemias, 5 mantle cell lymphomas, 1 multiple myeloma (lymphocytic variant), and 3 bone marrows not involved by any B-cell neoplasm. Our dual staining approach confirmed that only the neoplastic cells of HCL were positive for both CD103 and Pax5. CONCLUSIONS: - This dual-staining method is particularly helpful in cases with low-level involvement by HCL and can be used for determining minimal residual disease after treatment.
引用
- Rozenvald IB, Richardson MD, Brock L, et al. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity. Arch Pathol Lab Med. 2017. PMID: 28418282. doi:10.5858/arpa.2016-0215-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。